Mechanisms of Cardiac Growth, Death and Regeneration

心脏生长、死亡和再生的机制

基本信息

  • 批准号:
    8056942
  • 负责人:
  • 金额:
    $ 1.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal requests support for a Keystone Symposia meeting entitled Mechanisms of Cardiac Growth, Death and Regeneration, organized by Richard N. Kitsis, Ivor J. Benjamin and Charles E. Murry, which will be held in Keystone, Colorado from February 22 - 27, 2011. Cardiovascular disease is the major cause of death in the world. Although advances have been made in our understanding of cardiac biology and pathobiology, significant conceptual and practical gaps remain. This meeting - in combination with a concurrent meeting on Molecular Cardiology: Disease Mechanisms and Experimental Therapeutics - will address these gaps by focusing on fundamental mechanisms that regulate cardiac structure, function, and repair and how they relate to human disease. These paired cardiovascular-centric meetings bring diverse areas under an umbrella focused on the heart in health and disease. While primarily basic science-based, each meeting uniquely incorporates bench-to-bedside novel therapeutics sessions with the goal of broadening the attraction of this meeting to investigators from academia, pharma, biotechnology, and in the clinical enterprise. Both meetings deal with hypertrophy and heart failure, and disease. The focus of the Mechanisms of Cardiac Growth, Death and Regeneration meeting includes stem cells and stem cell/tissue engineering, and therefore this meeting occupies a unique position with respect to cardiac stem cell biology meetings. PUBLIC HEALTH RELEVANCE: Myocardial infarction and heart failure are the two major cardiac syndromes that are the most common causes of mortality in the United States and the world. The Keystone Symposia meeting on Mechanisms of Cardiac Growth, Death and Regeneration addresses the molecular underpinnings of the most fundamental decisions made by cardiac cells: a) to differentiate from their progenitors; b) to grow; or c) to survive or to die. This meeting, held in tandem with a meeting on Molecular Cardiology, will involve scientific questions relevant both to the cardiovascular system and stem cell biology as a whole.
描述(由申请人提供):本提案请求支持由Richard N. Kitsis,Ivor J. Benjamin和Charles E.默里,这将是在基斯通,科罗拉多从2011年2月22日至27日举行。心血管疾病是世界上主要的死亡原因。虽然我们对心脏生物学和病理生物学的理解已经取得了进展,但仍然存在重大的概念和实践差距。本次会议-结合分子心脏病学:疾病机制和实验治疗学的同期会议-将通过关注调节心脏结构,功能和修复的基本机制以及它们与人类疾病的关系来解决这些差距。这些成对的以心血管为中心的会议将不同的领域集中在健康和疾病的心脏上。虽然主要以基础科学为基础,但每次会议都独特地结合了从实验室到床边的新颖疗法会议,目的是扩大这次会议对学术界,制药,生物技术和临床企业研究人员的吸引力。这两个会议都涉及肥大和心力衰竭以及疾病。心脏生长、死亡和再生机制会议的重点包括干细胞和干细胞/组织工程,因此该会议在心脏干细胞生物学会议中占有独特的地位。 公共卫生相关性:心肌梗死和心力衰竭是两种主要的心脏综合征,是美国和世界上最常见的死亡原因。关于心脏生长、死亡和再生机制的Keystone研讨会会议讨论了心脏细胞做出的最基本决定的分子基础:a)与其祖细胞分化; B)生长;或c)生存或死亡。这次会议与分子心脏病学会议同时举行,将涉及与心血管系统和干细胞生物学相关的科学问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW D ROBERTSON其他文献

ANDREW D ROBERTSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW D ROBERTSON', 18)}}的其他基金

Environmental Epigenomics and Disease Susceptibility
环境表观基因组学和疾病易感性
  • 批准号:
    8130161
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
Mycobacteria: Physiology, Metabolism and Pathogenesis - Back to the Basics
分枝杆菌:生理学、代谢和发病机制 - 回到基础
  • 批准号:
    8055811
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
Immunity in the Respiratory Tract: Challenges of the Lung Environment
呼吸道免疫:肺部环境的挑战
  • 批准号:
    8057229
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
Hematopoiesis
造血作用
  • 批准号:
    8121912
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
Pathogenesis of Influenza: Virus-Host Interactions
流感的发病机制:病毒与宿主的相互作用
  • 批准号:
    8128073
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow
昆虫药物:明天的抗炎药物
  • 批准号:
    8124051
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
Immunoregulatory Networks
免疫调节网络
  • 批准号:
    8121921
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies
结核病:免疫学、细胞生物学和新型疫苗接种策略
  • 批准号:
    8055809
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses
NK 和 NKT 细胞生物学:先天反应的特异性和冗余
  • 批准号:
    8006107
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:
MicroRNAs and Human Disease - Olson, Chair
MicroRNA 与人类疾病 - Olson,主席
  • 批准号:
    8061929
  • 财政年份:
    2011
  • 资助金额:
    $ 1.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了